Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.24 USD | -6.31% | -3.11% | +61.66% |
Business Summary
Number of employees: 47
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cancer Therapeutics
100.0
%
| 16 | 100.0 % | 20 | 100.0 % | +21.60% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 16 | 100.0 % | 20 | 100.0 % | +21.60% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dan Hicklin
FOU | Founder | 60 | 18/10/17 |
Luke Evnin
FOU | Founder | 60 | 18/10/17 |
Timothy Trost
DFI | Director of Finance/CFO | 66 | 07/02/21 |
Chief Tech/Sci/R&D Officer | - | 14/06/21 | |
Randi Isaacs
CTO | Chief Tech/Sci/R&D Officer | 68 | 31/10/20 |
Ellen Lubman
IRC | Investor Relations Contact | 48 | 31/07/20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Luke Evnin
FOU | Founder | 60 | 18/10/17 |
Dan Hicklin
FOU | Founder | 60 | 18/10/17 |
Michael Sherman
BRD | Director/Board Member | 58 | 26/05/21 |
Briggs Morrison
BRD | Director/Board Member | 65 | 31/10/19 |
Alon Lazarus
BRD | Director/Board Member | 49 | 31/07/19 |
Derek DiRocco
BRD | Director/Board Member | 43 | 30/11/20 |
Director/Board Member | - | 01-03 | |
Meeta Chatterjee
BRD | Director/Board Member | 69 | 27/10/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 43,347,363 | 40,623,740 ( 93.72 %) | 0 | 93.72 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+61.66% | 289M | |
+0.17% | 42.86B | |
+10.92% | 42.74B | |
+44.30% | 41.36B | |
-6.20% | 27.68B | |
+5.23% | 25.15B | |
-24.79% | 18.63B | |
+26.69% | 12.37B | |
-3.13% | 11.92B | |
+6.57% | 11.21B |
- Stock Market
- Equities
- HOWL Stock
- Company Werewolf Therapeutics, Inc.